当前位置: 首页 >> 检索结果
201. Long-term effects of 4 popular diets on weight loss and cardiovascular risk factors: a systematic review of randomized controlled trials.
作者: Renée Atallah.;Kristian B Filion.;Susan M Wakil.;Jacques Genest.;Lawrence Joseph.;Paul Poirier.;Stéphane Rinfret.;Ernesto L Schiffrin.;Mark J Eisenberg.
来源: Circ Cardiovasc Qual Outcomes. 2014年7卷6期815-27页
We conducted a systematic review to examine the efficacy of the Atkins, South Beach, Weight Watchers (WW), and Zone diets, with a particular focus on sustained weight loss at ≥12 months.
202. Clinical outcomes after continuous-flow left ventricular assist device: a systematic review.
作者: Colleen K McIlvennan.;Kate H Magid.;Amrut V Ambardekar.;Jocelyn S Thompson.;Daniel D Matlock.;Larry A Allen.
来源: Circ Heart Fail. 2014年7卷6期1003-13页
Conveying the complex trade-offs of continuous-flow left ventricular assist devices is challenging and made more difficult by absence of an evidence summary for the full range of possible outcomes. We aimed to summarize the current evidence on outcomes of continuous-flow left ventricular assist devices.
203. Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis.
作者: Matteo Anselmino.;Mario Matta.;Fabrizio D'Ascenzo.;T Jared Bunch.;Richard J Schilling.;Ross J Hunter.;Carlo Pappone.;Thomas Neumann.;Georg Noelker.;Martin Fiala.;Emanuele Bertaglia.;Antonio Frontera.;Edward Duncan.;Chrishan Nalliah.;Pierre Jais.;Rukshen Weerasooriya.;Jon M Kalman.;Fiorenzo Gaita.
来源: Circ Arrhythm Electrophysiol. 2014年7卷6期1011-8页
Catheter ablation of atrial fibrillation (AFCA) is an established therapeutic option for rhythm control in symptomatic patients. Its efficacy and safety among patients with left ventricular systolic dysfunction is based on small populations, and data concerning long-term outcome are limited. We performed this meta-analysis to assess safety and long-term outcome of AFCA in patients with left ventricular systolic dysfunction, to evaluate predictors of recurrence and impact on left ventricular function.
204. CYP2C19 genotype has a greater effect on adverse cardiovascular outcomes following percutaneous coronary intervention and in Asian populations treated with clopidogrel: a meta-analysis.
作者: Michael J Sorich.;Andrew Rowland.;Ross A McKinnon.;Michael D Wiese.
来源: Circ Cardiovasc Genet. 2014年7卷6期895-902页
The degree to which cytochrome P450 (CYP) 2C19 genotype influences the effectiveness of clopidogrel remains uncertain because of considerable heterogeneity in results between studies and potential publication bias. Clopidogrel indication and ethnic population have been proposed to influence the effect of CYP2C19 genotype.
205. Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies.
作者: Maryam S Farvid.;Ming Ding.;An Pan.;Qi Sun.;Stephanie E Chiuve.;Lyn M Steffen.;Walter C Willett.;Frank B Hu.
来源: Circulation. 2014年130卷18期1568-78页
Previous studies on intake of linoleic acid (LA), the predominant n-6 fatty acid, and coronary heart disease (CHD) risk have generated inconsistent results. We performed a systematic review and meta-analysis of prospective cohort studies to summarize the evidence regarding the relation of dietary LA intake and CHD risk.
206. Efficacy of catheter ablation for persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized and nonrandomized controlled trials.
作者: Gareth J Wynn.;Moloy Das.;Laura J Bonnett.;Sandeep Panikker.;Tom Wong.;Dhiraj Gupta.
来源: Circ Arrhythm Electrophysiol. 2014年7卷5期841-52页
Catheter ablation (CA) is commonly performed for persistent atrial fibrillation, but few high-quality randomized controlled trials (RCTs) exist, leading to funding restrictions being proposed in several countries. We performed a random-effects meta-analysis of RCTs and non-RCTs to assess the efficacy of CA for persistent atrial fibrillation.
207. Catheter ablation and antiarrhythmic drug therapy as first- or second-line therapy in the management of atrial fibrillation: systematic review and meta-analysis.
作者: Abdur Rahman Khan.;Sobia Khan.;Mujeeb A Sheikh.;Sadik Khuder.;Blair Grubb.;George V Moukarbel.
来源: Circ Arrhythm Electrophysiol. 2014年7卷5期853-60页
The optimal management of atrial fibrillation remains unclear. We performed a meta-analysis of randomized controlled trials to examine the safety and the efficacy of catheter ablation (CA) when compared with antiarrhythmic drug therapy both as first- and second-line therapy for the maintenance of sinus rhythm in atrial fibrillation.
208. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
作者: Duminda N Wijeysundera.;Dallas Duncan.;Chileshe Nkonde-Price.;Salim S Virani.;Jeffrey B Washam.;Kirsten E Fleischmann.;Lee A Fleisher.; .
来源: Circulation. 2014年130卷24期2246-64页
To review the literature systematically to determine whether initiation of beta blockade within 45 days prior to noncardiac surgery reduces 30-day cardiovascular morbidity and mortality rates.
209. Sex differences in long-term mortality after myocardial infarction: a systematic review.
作者: Emily M Bucholz.;Neel M Butala.;Saif S Rathore.;Rachel P Dreyer.;Alexandra J Lansky.;Harlan M Krumholz.
来源: Circulation. 2014年130卷9期757-67页
Studies of sex differences in long-term mortality after acute myocardial infarction have reported mixed results. A systematic review is needed to characterize what is known about sex differences in long-term outcomes and to define gaps in knowledge.
210. Association between operator procedure volume and patient outcomes in percutaneous coronary intervention: a systematic review and meta-analysis.
作者: Jordan B Strom.;Neil J Wimmer.;Jason H Wasfy.;Kevin Kennedy.;Robert W Yeh.
来源: Circ Cardiovasc Qual Outcomes. 2014年7卷4期560-6页
The growth of centers capable of performing percutaneous coronary intervention (PCI) has outpaced population growth despite declining incidence of myocardial infarction and prevalence of coronary artery disease, potentially increasing the proportion of operators falling below minimal yearly volume standards set by professional societies.
211. Noninducibility in postinfarction ventricular tachycardia as an end point for ventricular tachycardia ablation and its effects on outcomes: a meta-analysis.
作者: Hamid Ghanbari.;Kazim Baser.;Miki Yokokawa.;William Stevenson.;Paolo Della Bella.;Pasquale Vergara.;Thomas Deneke.;Karl-Heinz Kuck.;Hans Kottkamp.;She Fei.;Fred Morady.;Frank Bogun.
来源: Circ Arrhythm Electrophysiol. 2014年7卷4期677-83页
Although ventricular tachycardia (VT) ablation is a widely used therapy for patients with VT, the ideal end points for this procedure are not well defined. We performed a meta-analysis of the published literature to assess the predictive value of noninducibility of postinfarction VT for long-term outcomes after VT ablation.
212. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study.
作者: Andrew E Moran.;Mohammad H Forouzanfar.;Gregory A Roth.;George A Mensah.;Majid Ezzati.;Christopher J L Murray.;Mohsen Naghavi.
来源: Circulation. 2014年129卷14期1483-92页
Ischemic heart disease (IHD) is the leading cause of death worldwide. The Global Burden of Diseases, Risk Factors and Injuries 2010 Study estimated global and regional IHD mortality from 1980 to 2010.
213. The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study.
作者: Andrew E Moran.;Mohammad H Forouzanfar.;Gregory A Roth.;George A Mensah.;Majid Ezzati.;Abraham Flaxman.;Christopher J L Murray.;Mohsen Naghavi.
来源: Circulation. 2014年129卷14期1493-501页
Ischemic heart disease (IHD) burden consists of years of life lost from IHD deaths and years of disability lived with 3 nonfatal IHD sequelae: nonfatal acute myocardial infarction, angina pectoris, and ischemic heart failure. Our aim was to estimate the global and regional burden of IHD in 1990 and 2010.
214. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association.
作者: Judith H Lichtman.;Erika S Froelicher.;James A Blumenthal.;Robert M Carney.;Lynn V Doering.;Nancy Frasure-Smith.;Kenneth E Freedland.;Allan S Jaffe.;Erica C Leifheit-Limson.;David S Sheps.;Viola Vaccarino.;Lawson Wulsin.; .
来源: Circulation. 2014年129卷12期1350-69页
Although prospective studies, systematic reviews, and meta-analyses have documented an association between depression and increased morbidity and mortality in a variety of cardiac populations, depression has not yet achieved formal recognition as a risk factor for poor prognosis in patients with acute coronary syndrome by the American Heart Association and other health organizations. The purpose of this scientific statement is to review available evidence and recommend whether depression should be elevated to the status of a risk factor for patients with acute coronary syndrome.
215. Effect of childhood obesity prevention programs on blood pressure: a systematic review and meta-analysis.
作者: Li Cai.;Yang Wu.;Renee F Wilson.;Jodi B Segal.;Miyong T Kim.;Youfa Wang.
来源: Circulation. 2014年129卷18期1832-9页
Childhood overweight and obesity are associated with elevated blood pressure (BP). However, little is known about how childhood obesity lifestyle prevention programs affect BP. We assessed the effects of childhood obesity prevention programs on BP in children in developed countries.
216. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.
作者: Vern Hsen Tan.;Stephen B Wilton.;Vikas Kuriachan.;Glen L Sumner.;Derek V Exner.
来源: Circ Arrhythm Electrophysiol. 2014年7卷1期164-70页
Patients who receive implantable cardioverter defibrillator therapies are at higher risk of death versus those who do not. Programmed settings to reduce nonessential implantable cardioverter defibrillator therapies (therapy reduction programming) have been developed but may have adverse effects. This systematic review and meta-analysis assessed the relationship between therapy reduction programming with the risks of death from any cause, implantable cardioverter defibrillator shocks, and syncope.
217. Comparative effectiveness of wide antral versus ostial pulmonary vein isolation: a systematic review and meta-analysis.
作者: Riccardo Proietti.;Pasquale Santangeli.;Luigi Di Biase.;Jacqueline Joza.;Martin Louis Bernier.;Yang Wang.;Antonio Sagone.;Maurizio Viecca.;Vidal Essebag.;Andrea Natale.
来源: Circ Arrhythm Electrophysiol. 2014年7卷1期39-45页
For the past decade, electric pulmonary vein isolation (PVI) has become a procedure implemented worldwide for the treatment of atrial fibrillation. Currently, 2 main approaches are used for PVI: ostial isolation of the PVs and wide antral PVI. The aims of this systematic review are to evaluate the relative merits of each technique with a pooled comparative analysis of efficacy and complications.
218. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis.
作者: Sujith Kuruvilla.;Nebiyu Adenaw.;Arabindra B Katwal.;Michael J Lipinski.;Christopher M Kramer.;Michael Salerno.
来源: Circ Cardiovasc Imaging. 2014年7卷2期250-258页
Late gadolinium enhancement (LGE) by cardiac MR (CMR) is a predictor of adverse cardiovascular outcomes in patients with nonischemic cardiomyopathy (NICM). However, these findings are limited by single-center studies, small sample sizes, and low event rates. We performed a meta-analysis to evaluate the prognostic role of LGE by CMR (LGE-CMR) imaging in patients with NICM.
220. Complications of catheter ablation of atrial fibrillation: a systematic review.
作者: Aakriti Gupta.;Tharani Perera.;Anand Ganesan.;Thomas Sullivan.;Dennis H Lau.;Kurt C Roberts-Thomson.;Anthony G Brooks.;Prashanthan Sanders.
来源: Circ Arrhythm Electrophysiol. 2013年6卷6期1082-8页
Atrial fibrillation ablation is an established therapy; however, limited data are available on associated complications. This systematic review determines the incidence and potential predictors of acute complications.
|